Bio-Connect

HSD17B3 antibody

GTX114480
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetHSD17B3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    HSD17B3 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.92 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3293
  • Target name
    HSD17B3
  • Target description
    hydroxysteroid 17-beta dehydrogenase 3
  • Target synonyms
    17-beta-HSD 3; 17-beta-HSD3; 17-beta-hydroxysteroid dehydrogenase type 3; EDH17B3; estradiol 17-beta-dehydrogenase 2; hydroxysteroid dehydrogenase 3; SDR12C2; short chain dehydrogenase/reductase family 12C member 2; testicular 17-beta-hydroxysteroid dehydrogenase; testosterone 17-beta-dehydrogenase 3
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP37058
  • Protein Name
    Testosterone 17-beta-dehydrogenase 3
  • Scientific Description
    This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone. It preferentially uses NADP as cofactor. Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Estrogen synthesis in the stomach of Sprague-Dawley rats: comparison to Wistar rats. Kobayashi H et al., 2021 Feb 6, Exp Anim
    Read more
  • Transplantation of encapsulated human Leydig-like cells: A novel option for the treatment of testosterone deficiency. Feng X et al., 2021 Jan 1, Mol Cell Endocrinol
    Read more
  • Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential. Zimmer BM et al., 2016 Aug, Horm Cancer
    Read more